NPC-12G Gel 0.2% Sirolimus PK Bridging Study

Status:
Completed

Trial end date:
2019-06-17

Target enrollment:

Participant gender:

This study is designed to describe the relative systemic bioavailability of topical and oral sirolimus formulations.

Phase 1

Nobelpharma

Everolimus
Sirolimus